Richard Newitter
Stock Analyst at Truist Securities
(4.08)
# 244
Out of 4,829 analysts
361
Total ratings
55.7%
Success rate
9.33%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Buy | $127 → $117 | $79.81 | +46.60% | 18 | May 8, 2025 | |
| TFX Teleflex | Maintains: Hold | $140 → $137 | $129.27 | +5.98% | 38 | May 5, 2025 | |
| SYK Stryker | Maintains: Hold | $390 → $400 | $388.96 | +2.84% | 20 | May 5, 2025 | |
| GKOS Glaukos | Reiterates: Buy | $140 → $135 | $94.17 | +43.36% | 5 | May 1, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $140 → $150 | $121.31 | +23.65% | 7 | Apr 28, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $113 → $117 | $102.72 | +13.90% | 12 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $605 → $590 | $558.85 | +5.57% | 28 | Apr 23, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $90 → $70 | $55.03 | +27.20% | 14 | Apr 11, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $51 | $43.55 | +17.12% | 3 | Apr 11, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $9.5 → $8 | $7.36 | +8.77% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $85.73 | +4.98% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $23.62 | +1.61% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $13.45 | +41.32% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $80 | $59.15 | +35.25% | 26 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $78 → $75 | $74.36 | +0.86% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $139.74 | +3.76% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $235 | $156.26 | +50.39% | 24 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $97.57 | +15.81% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $299.00 | -4.68% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $18.67 | +12.48% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.93 | +43.58% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $94.82 | -13.52% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $173.27 | +44.28% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.06 | +751.06% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $189.07 | +307.26% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $58.51 | +45.27% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.00 | +42.86% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $11.57 | +133.36% | 5 | Feb 23, 2021 |
Lantheus Holdings
May 8, 2025
Maintains: Buy
Price Target: $127 → $117
Current: $79.81
Upside: +46.60%
Teleflex
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $129.27
Upside: +5.98%
Stryker
May 5, 2025
Maintains: Hold
Price Target: $390 → $400
Current: $388.96
Upside: +2.84%
Glaukos
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $94.17
Upside: +43.36%
Integer Holdings
Apr 28, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $121.31
Upside: +23.65%
Boston Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $113 → $117
Current: $102.72
Upside: +13.90%
Intuitive Surgical
Apr 23, 2025
Maintains: Buy
Price Target: $605 → $590
Current: $558.85
Upside: +5.57%
PROCEPT BioRobotics
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $55.03
Upside: +27.20%
Vericel
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $43.55
Upside: +17.12%
Treace Medical Concepts
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $7.36
Upside: +8.77%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $85.73
Upside: +4.98%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $23.62
Upside: +1.61%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $13.45
Upside: +41.32%
Apr 11, 2025
Maintains: Hold
Price Target: $82 → $80
Current: $59.15
Upside: +35.25%
Apr 11, 2025
Maintains: Hold
Price Target: $78 → $75
Current: $74.36
Upside: +0.86%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $139.74
Upside: +3.76%
Feb 11, 2025
Maintains: Buy
Price Target: $250 → $235
Current: $156.26
Upside: +50.39%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $97.57
Upside: +15.81%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $299.00
Upside: -4.68%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $18.67
Upside: +12.48%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.93
Upside: +43.58%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $94.82
Upside: -13.52%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $173.27
Upside: +44.28%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.06
Upside: +751.06%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $189.07
Upside: +307.26%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $58.51
Upside: +45.27%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $14.00
Upside: +42.86%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $11.57
Upside: +133.36%